logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Multiple Myeloma

    FiltersReset Filters
    42 results

    • aphexda

      (Motixafortide)
      BioLineRx USA Inc
      Usage: APHEXDA is indicated, in combination with filgrastim (G-CSF), for mobilizing hematopoietic stem cells into peripheral blood for collection and autologous transplantation in patients with multiple myeloma.

    • bortezomib

      (Bortezomib)
      Novadoz Pharmaceuticals LLC
      Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

    • bortezomib

      (BORTEZOMIB)
      Hospira, Inc.
      Usage: Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

    • bortezomib

      (bortezomib)
      Hikma Pharmaceuticals USA Inc.
      Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

    • bortezomib

      (Bortezomib)
      NorthStar RxLLC
      Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

    • boruzu

      (Bortezomib)
      Amneal Pharmaceuticals LLC
      Usage: BORUZU is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

    • carmustine

      (CARMUSTINE)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Carmustine for Injection, USP is indicated for palliative therapy as a single agent or in combination therapy for brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).

    • carmustine

      (CARMUSTINE)
      Sandoz Inc.
      Usage: Carmustine for injection is indicated for palliative therapy as a single agent or in combination for brain tumors, multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).

    • cyclophosphamide

      (Cyclophosphamide for Injection)
      Slate Run Pharmaceuticals, LLC
      Usage: Cyclophosphamide for Injection is indicated for treating various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and solid tumors like breast cancer and ovarian adenocarcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome unresponsive to corticosteroid therapy.

    • cyclophosphamide

      (cyclophosphamide injection, solution)
      Baxter Healthcare Corporation
      Usage: Cyclophosphamide Injection is indicated for treating malignant lymphomas, multiple myeloma, various leukemias, advanced mycosis fungoides, disseminated neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is often used alone or in combination with other antineoplastic agents.